Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3494539

In Collections

This item can be found in the following collections:

Kalot, M.A.; Husainat, N.; Alayli, A. el; Abughanimeh, O.; Diab, O.; Tayiem, S.; ... ; Mustafa, R.A. (2021)

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis

Article / Letter to editor
von Willebrand disease (VWD) is associated with significant morbidity as a result of excessive mucocutaneous bleeding. Early diagnosis and treatment are important to prevent and treat these symptoms. We systematically reviewed the accuracy of diagnostic tests using different cutoff values of von Willebrand factor antigen (VWF:Ag) and platelet-dependent von Willebrand factor (VWF) activity assays in the diagnosis of VWD. We searched Cochrane Central Register for Controlled Trials, MEDLINE, and Embase databases for eligible studies. We pooled estimates of sensitivity and specificity and reported patient-important outcomes when relevant. This review included 21 studies that evaluated VWD diagnosis. The results showed low certainty in the evidence for a net health benefit from reconsidering the diagnosis of VWD vs removing the disease diagnosis in patients with VWF levels that have normalized with age. For the diagnosis of type 1 VWD, VWF sequence variants were detected in 75% to 82% of...Show morevon Willebrand disease (VWD) is associated with significant morbidity as a result of excessive mucocutaneous bleeding. Early diagnosis and treatment are important to prevent and treat these symptoms. We systematically reviewed the accuracy of diagnostic tests using different cutoff values of von Willebrand factor antigen (VWF:Ag) and platelet-dependent von Willebrand factor (VWF) activity assays in the diagnosis of VWD. We searched Cochrane Central Register for Controlled Trials, MEDLINE, and Embase databases for eligible studies. We pooled estimates of sensitivity and specificity and reported patient-important outcomes when relevant. This review included 21 studies that evaluated VWD diagnosis. The results showed low certainty in the evidence for a net health benefit from reconsidering the diagnosis of VWD vs removing the disease diagnosis in patients with VWF levels that have normalized with age. For the diagnosis of type 1 VWD, VWF sequence variants were detected in 75% to 82% of patients with VWF:Ag < 0.30 IU/mL and in 44% to 60% of patients with VWF:Ag between 0.30 and 0.50 IU/mL. A sensitivity of 0.90 (95% confidence interval [CI], 0.83-0.94) and a specificity of 0.91 (95% CI, 0.76-0.97) were observed for a platelet-dependent VWF activity/VWF:Ag ratio < 0.7 in detecting type 2 VWD (moderate certainty in the test accuracy results). VWF:Ag and platelet-dependent activity are continuous variables that are associated with an increase in bleeding risk with decreasing levels. This systematic review shows that using a VWF activity/VWF:Ag ratio < 0.7 vs lower cutoff levels in patients with an abnormal initial VWD screen is more accurate for the diagnosis of type 2 VWD.Show less
All authors
Kalot, M.A.; Husainat, N.; Alayli, A. el; Abughanimeh, O.; Diab, O.; Tayiem, S.; Madoukh, B.; Dimassi, A.B.; Qureini, A.; Ameer, B.; Eikenboom, J.C.J.; Giraud, N.; McLintock, C.; McRae, S.; Montgomery, R.R.; O'Donnell, J.S.; Scappe, N.; Sidonio, R.F.; Brignardello-Petersen, R.; Flood, V.H.; Connell, N.T.; James, P.D.; Mustafa, R.A.
Date
2021-12-31
Journal
Blood Advances
Volume
6
Issue
1
Pages
62 - 71
DOI
doi:10.1182/bloodadvances.2021005430